Reduced CD44+ expression via the Scl/Tal1 pathway, increased CML stem cell cycling, and restoration of TKI-sensitivity were also noted [152,154]. The gene discussed is TAL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.